Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

167200

registered interest
date	02/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Wallace of Saltaire on 1 December (HL3088), what was the overall incidence of stillbirths from in vitro fertilisation pregnancies for the past decade following foetal reduction in either the first trimester or early in the second trimester that affected (1) the remaining twin from the same twin pregnancy, (2) one of the remaining triplets from the same pregnancy, and (3) both of the remaining triplets from the same pregnancy, according to data held by the Human Fertilisation and Embryology Authority.
tabling member printed	Lord Alton of Liverpool
uin	HL3301
answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that in the decade preceding 31 December 2012, the HFEA register records one incidence of a still birth following an embryo reduction at week 13 in a twin pregnancy, and one incidence of a still birth following a double embryo reduction at 12 weeks in a triplet pregnancy. Within this time period there are no other records of incidences of still births following foetal reductions in multiple pregnancies taking place within the first 16 weeks of pregnancy.</p><p> </p><p> </p><p> </p><p>The first trimester has been taken as weeks 0-13 and ‘early in the second trimester’ as weeks 14-16.</p><p> </p><p> </p><p> </p><p>The HFEA has also advised that any records held on its register after 31 December 2012 are not yet verified.</p><p> </p> answering member printed Earl Howe question first answered 15/12/2014 12:14:38 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

167201

registered interest
date	02/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 17 November (HL2642) and on 2 December (HL2905), whether they consider that mutations affecting DNA Polymerase Gamma might in turn ever be potentially responsible for disease-associated mitochondrial DNA mutations such as those listed in Annex D of the "Mitochondrial Donation" consultation document; and if not, why not.
tabling member printed	Lord Alton of Liverpool
uin	HL3302
answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>We have been advised that there is no evidence to suggest that mutations affecting DNA polymerase gamma result in high levels of the mitochondrial DNA mutations responsible for the mitochondrial diseases listed in Annex D of the mitochondrial donation consultation document. As stated in my previous answer of 17 November 2014 (<em>Official Report</em>, col WA59), mitochondrial donation techniques would only be used for patients that have an inherited mitochondrial DNA mutation and could not be used for those diseases in which faulty mitochondria arise from a nuclear gene mutation.</p><p> </p> answering member printed Earl Howe question first answered 15/12/2014 12:29:26 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

167202

registered interest
date	02/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 2 December (HL2905), what was the empirical evidence upon which the Human Fertilisation and Embryology Authority based its recommendation regarding multi-foetal pregnancy reduction.
tabling member printed	Lord Alton of Liverpool
uin	HL3303
answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that as stated in my Written Answer of 17 November 2014 (<em>Official Report</em>, Columns WA 60-61), when developing its policy on multiple births, the HFEA commissioned an Expert Group on Multiple Births after IVF (in vitro fertilisation), which concluded that the prevention of multiple pregnancies through single embryo transfer should be preferred to multifetal pregnancy reduction.</p><p> </p><p> </p><p> </p><p>The evidence this recommendation was based on is outlined in the Expert Group’s report, available on the HFEA’s website at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hfea.gov.uk/docs/MBSET_report.pdf" target="_blank">http://www.hfea.gov.uk/docs/MBSET_report.pdf</a></p><p> </p> answering member printed Earl Howe question first answered 15/12/2014 12:15:26 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

167203

registered interest
date	02/12/2014
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Churches: Repairs and Maintenance
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many court cases have been brought by parochial church councils to recover chancel repair liability since the Aston Cantlow judgment by the House of Lords in 2003.
tabling member printed	Lord Avebury
uin	HL3304
answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>The decision of the House of Lords in the case of <em>Parochial Church Council of the Parish of Aston Cantlow and Wilmcote with Billesley, Warwickshire v. Wallbank and another </em>[2003] UKHL 37 confirmed that chancel repair liability was a valid and enforceable property right. Before 13 October 2013 the liability did not have to be entered on the land register to bind buyers of registered land. Now buyers can be certain whether a property may be subject to the liability before they buy, helping them to make informed decisions.</p><p> </p><p>Information as to the number of cases parochial church councils have brought since June 2003 to recover chancel repair liability is not available and could only be obtained from court records at disproportionate expense. The Government is however aware that not all parochial church councils decided to register their entitlement to the benefit of the liability.</p> answering member printed Lord Faulks question first answered 16/12/2014 17:09:44 answering member 4183 label Biography information for Lord Faulks
tabling member	1665 label Biography information for Lord Avebury

167204

registered interest
date	02/12/2014
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Bangladesh
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what representations they and the European Union High Representative on Foreign Affairs respectively have made to the government of Bangladesh about its Foreign Donations (Voluntary Activities) Regulation Bill 2014.
tabling member printed	Lord Avebury
uin	HL3305
answer	answer is ministerial correction date of answer 10/12/2014 answer text <p>The Government is aware that the Government of Bangladesh has approved the draft Foreign Donations Act (FDA) to go to Parliament. We are following the development of the new legislation closely. The Government, EU and other like-minded partners raised our concerns over restricting civil society with the Government of Bangladesh during the drafting of the Act. This included the Department for International Development (DfID) Country Representative leading a delegation to report donors’ concerns over aspects of the Act.</p><p> </p><p>During the meeting between the Prime Minister, my right hon. Friend the Member for Witney (Mr Cameron), and the Bangladesh Prime Minister in July, both agreed on the importance of an open society and political system in which democratic political participation and media freedoms are respected. Most recently in October, the former DfID Parliamentary Under-Secretary of State, my right hon. Friend the Member for Hornsey and Wood Green (Lynne Featherstone), set out UK concerns on the FDA during her visit to Bangladesh, stressing that the Act risked penalising genuine donor and civil society activity.</p> answering member printed Baroness Anelay of St Johns question first answered 10/12/2014 14:29:02 answering member 3474 label Biography information for Baroness Anelay of St Johns
tabling member	1665 label Biography information for Lord Avebury

167205

registered interest
date	02/12/2014
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: HIV Infection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many of the Department for International Development's bilateral HIV programmes actively incorporate (1) screening for, and (2) diagnosis of, tuberculosis.
tabling member printed	Baroness Nye
uin	HL3306
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>Last year’s review of our 2011 HIV Position Paper highlighted integrated responses to tackling HIV and tuberculosis co-infection as a key area of current and on-going work.</p><p> </p><p> </p><p> </p><p>DFID health advisers are aware of the package of collaborative TB and HIV activities recommended by WHO and are able to discuss these with the TB and HIV control programmes in the countries we support. However due to our current financial and management information systems we are unable to report on the specific interventions requested without incurring disproportionate cost.</p><p> </p><p> </p><p> </p><p>Increasingly the Global Fund is the main financing mechanism for the UK’s support to TB and HIV. DFID has been strongly involved in the recent Global Fund requirement for countries burdened by the two diseases to put forward a unified and integrated application for joint TB-HIV programmes.</p><p> </p> answering member printed Baroness Northover grouped question UIN HL3307 HL3308 HL3309 question first answered 08/12/2014 12:17:06 answering member 2539 label Biography information for Baroness Northover
tabling member	4180 label Biography information for Baroness Nye

167206

registered interest
date	02/12/2014
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: HIV Infection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many of the Department for International Development's bilateral HIV programmes seek to prevent tuberculosis among people living with HIV through (1) infection control, (2) active case finding, and (3) initiation of preventative therapies.
tabling member printed	Baroness Nye
uin	HL3307
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>Last year’s review of our 2011 HIV Position Paper highlighted integrated responses to tackling HIV and tuberculosis co-infection as a key area of current and on-going work.</p><p> </p><p> </p><p> </p><p>DFID health advisers are aware of the package of collaborative TB and HIV activities recommended by WHO and are able to discuss these with the TB and HIV control programmes in the countries we support. However due to our current financial and management information systems we are unable to report on the specific interventions requested without incurring disproportionate cost.</p><p> </p><p> </p><p> </p><p>Increasingly the Global Fund is the main financing mechanism for the UK’s support to TB and HIV. DFID has been strongly involved in the recent Global Fund requirement for countries burdened by the two diseases to put forward a unified and integrated application for joint TB-HIV programmes.</p><p> </p> answering member printed Baroness Northover grouped question UIN HL3306 HL3308 HL3309 question first answered 08/12/2014 12:17:06 answering member 2539 label Biography information for Baroness Northover
tabling member	4180 label Biography information for Baroness Nye

167207

registered interest
date	02/12/2014
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: HIV Infection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to ensure that the HIV and tuberculosis co-ordinating bodies in countries where the Department for International Development has a bilateral HIV programme are (1) developing integrated tuberculosis and HIV services, and (2) carrying out joint tuberculosis and HIV planning.
tabling member printed	Baroness Nye
uin	HL3308
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>Last year’s review of our 2011 HIV Position Paper highlighted integrated responses to tackling HIV and tuberculosis co-infection as a key area of current and on-going work.</p><p> </p><p> </p><p> </p><p>DFID health advisers are aware of the package of collaborative TB and HIV activities recommended by WHO and are able to discuss these with the TB and HIV control programmes in the countries we support. However due to our current financial and management information systems we are unable to report on the specific interventions requested without incurring disproportionate cost.</p><p> </p><p> </p><p> </p><p>Increasingly the Global Fund is the main financing mechanism for the UK’s support to TB and HIV. DFID has been strongly involved in the recent Global Fund requirement for countries burdened by the two diseases to put forward a unified and integrated application for joint TB-HIV programmes.</p><p> </p> answering member printed Baroness Northover grouped question UIN HL3306 HL3307 HL3309 question first answered 08/12/2014 12:17:06 answering member 2539 label Biography information for Baroness Northover
tabling member	4180 label Biography information for Baroness Nye

167208

registered interest
date	02/12/2014
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: HIV Infection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the remarks by the Secretary of State for International Development on 5 March (HC Deb, col 879), what is the timeframe for integrating collaborative tuberculosis and HIV activities into all Department for International Development HIV programmes.
tabling member printed	Baroness Nye
uin	HL3309
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>Last year’s review of our 2011 HIV Position Paper highlighted integrated responses to tackling HIV and tuberculosis co-infection as a key area of current and on-going work.</p><p> </p><p> </p><p> </p><p>DFID health advisers are aware of the package of collaborative TB and HIV activities recommended by WHO and are able to discuss these with the TB and HIV control programmes in the countries we support. However due to our current financial and management information systems we are unable to report on the specific interventions requested without incurring disproportionate cost.</p><p> </p><p> </p><p> </p><p>Increasingly the Global Fund is the main financing mechanism for the UK’s support to TB and HIV. DFID has been strongly involved in the recent Global Fund requirement for countries burdened by the two diseases to put forward a unified and integrated application for joint TB-HIV programmes.</p><p> </p> answering member printed Baroness Northover grouped question UIN HL3306 HL3307 HL3308 question first answered 08/12/2014 12:17:07 answering member 2539 label Biography information for Baroness Northover
tabling member	4180 label Biography information for Baroness Nye

167209

registered interest
date	02/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Finance
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how much money they have redirected from acute services to community services in England, for example through community provision for people with severe learning difficulties; and how much money is flowing in the opposite direction.
tabling member printed	Lord Mawson
uin	HL3310
answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>Local National Health Service clinical commissioning groups (CCGs) are responsible for funding the majority of acute and community services. NHS England sets CCG funding allocations but does not direct CCGs in how those funds should be applied between different services. The in-year reporting of CCG expenditure does not provide the fine detail on movements in expenditure between acute services and community services. However, the NHS does produce programme budgeting data on historical expenditure which provides information on expenditure by major health condition as well as, for last three years, a breakdown by care-setting. The data on expenditure by care-settings is relatively new and is not yet considered robust enough to make comparisons of expenditure by care-setting. The 2013-14 data will be available in 2015, under a revised format.</p><p> </p> answering member printed Earl Howe question first answered 16/12/2014 16:28:02 answering member 2000 label Biography information for Earl Howe
tabling member	3830 label Biography information for Lord Mawson